Abstract
Periodic acceleration in the direction of the spinal axis through repetitive movements
of a horizontal motion platform increases intravascular pulsatile shear stress. We
hypothesized that periodic acceleration enhances release of nitric oxide (NO) in healthy
subjects. We enrolled 8 healthy volunteers [39 ± 10 (SD) years]. Periodic acceleration
was applied with the motion platform at a frequency of 2–3 Hz with approximately ±
0.25 g for 45 min in the fasting state. The procedure was repeated 20 times over 31
± 10 days. Venous blood was sampled to determine plasma levels of NO, vascular endothelial
growth factor (VEGF), tissue plasminogen activator (t-PA), and monocyte chemoattractant
protein-1 (MCP-1) before and immediately after the first and 20th session. All the
8 subjects completed the 20 sessions without any adverse side effect. Periodic acceleration
significantly increased the plasma levels of endproducts of NO from 17 ± 3 μmol/L
at baseline and immediately after the first session to 24 ± 9 μmol/L immediately after
the 20th session (each p < 0.05). Treatment with the motion platform did not change significantly the plasma
levels of VEGF, t-PA, and MCP-1. These findings provide new evidence that periodic
acceleration with the motion platform enhances release of NO.